Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers

The International Agency for Research on Cancer in 2014 reported that an estimated 529,000 new cancer cases in the oral cavity, lip and pharynx occurred worldwide in 2012, with 292,000 deaths. When the main subsites are examined separately, they do not rank highly; combined, however, they would rank as the seventh most frequent type of cancer and the ninth most common cause of cancer death [1]. The most common oral cancer, oral squamous cell carcinoma (OSCC) may arise from potentially malignant oral disorders (PMODs) such as oral leukoplakia (OL) and oral submucous fibrosis, with a variable transformation rate [2].

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2vJGWOS